# MARQUETTE UNIVERSITY: Assessing the Safety and Efficacy of SXC-2023 in a Phase 2A Clinical Trial for Cocaine Use Disorder

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | MARQUETTE UNIVERSITY |
| Location | MILWAUKEE, WI |
| Project | Assessing the Safety and Efficacy of SXC-2023 in a Phase 2A Clinical Trial for Cocaine Use Disorder |
| Project number | 1U01DA065419-01 |
| Mechanism | U01 |
| Institute | National Institute on Drug Abuse |
| Award | $4,240,112 |
| Awarded | 2026-09-04 |
| Project period | 2026-09-15 to 2029-06-30 |
| UEI | HKJCKTFJNBM7 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11324833). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.